AKEBIA THERAPEUTICS, INC.

Company

Akebia Therapeutics, Inc.

Filed

January 6, 2015

Accession Number

0000790502-15-000007

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →